EKEiji Kondo

Eiji Kondo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eiji Kondo has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Go Sato

    Department of Otolaryngology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

    4 shared publications
  • Takahiro Azuma

    Department of Otolaryngology-Head and Neck Surgery, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan

    3 shared publications
  • Yoshiaki Kitamura

    Department of Otolaryngology, Graduate School of Medicine, Tokushima University, Tokushima, Japan

    3 shared publications
  • Hiroshi Ando

    Department of Biology, School of Dentistry, Matsumoto Dental University, 1780 Gobara, Hirooka, Shiojiri, Nagano 399-0781, Japan

    2 shared publications
  • Junya Fukuda

    Department of Otolaryngology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto, Tokushima 770-8503, Japan

    2 shared publications
  • Naokazu Asanuma

    Department of Oral Physiology, School of Dentistry Matsumoto Dental University Nagano Japan

    2 shared publications

Latest Publications

  • Open Access

    Effect of dupilumab on otitis media associated with eosinophilic chronic rhinosinusitis

    by Seiichiro Kamimura, Keisuke Ishitani, Ryota Morozumi, Eiji Kondo, Takahiro Azuma, Go Sato, Yoshiaki Kitamura


  • Development of receptive vocabulary and verbal intelligence in Japanese children with unilateral hearing loss

    by Takaaki Takeyama, Aki Shimada, Yuki Sakamoto, Toshihito Aoki, Eiji Kondo, Seiichi Nakano, Junya Fukuda, Takahiro Azuma, Go Sato, Hidehiko Okamoto, et al.


  • New method to evaluate sequelae of static facial asymmetry in patients with facial palsy using three-dimensional scanning analysis

    by Takahiro Azuma, Teruhiko Fuchigami, Katsuhiko Nakamura, Eiji Kondo, Go Sato, Yoshiaki Kitamura, Noriaki Takeda


  • Long-term changes in serum squamous cell carcinoma antigen levels after surgery in patients with sinonasal inverted papilloma

    by Yoshiaki Kitamura, Seiichiro Kamimura, Tatsuya Fujii, Ryo Kanamura, Junya Fukuda, Eiji Kondo, Takahiro Azuma, Go Sato, Noriaki Takeda


  • Drug holiday clinical relevance verification for antiresorptive agents in medication-related osteonecrosis cases of the jaw

    by Saki Hayashida, Souichi Yanamoto, Shigeyuki Fujita, Takumi Hasegawa, Takahide Komori, Yuka Kojima, Hironori Miyamoto, Yasuyuki Shibuya, Nobuhiro Ueda, Tadaaki Kirita, et al.

    Treatment strategies of medication-related osteonecrosis of the jaw (MRONJ) are controversial. Recently, surgical treatment has been reported as superior to nonsurgical treatment, but the contribution discontinued antiresorptive agent use during MRONJ treatment remains unclear. This study aimed to evaluate the efficacy of drug holidays and treatment strategies in MRONJ cases. Four-hundred and twenty-seven patients with MRONJ treated at nine hospitals from 2009 to 2017 were included in this multicenter retrospective study. Multivariate Cox regression analysis showed that the primary disease (osteoporosis or malignant tumor), diabetes, serum albumin, and treatment method (surgical or nonsurgical) were significantly correlated with the cure rate. The cumulative 1-year cure rates in the surgical and nonsurgical treatment groups were 64.7% and 18.2%, respectively. However, discontinuing antiresorptive agents did not influence the treatment outcome in the cohort overall, or in 230 patients after performing propensity score matching among the discontinuation and continuation groups. When stratifying by treatment method, antiresorptive agent discontinuation significantly increased the cure rate in patients with osteoporosis who underwent nonsurgical treatment. In patients with malignant tumors undergoing nonsurgical therapy, discontinuing the antiresorptive agent was associated with a better treatment outcome, but not with statistical significance. In contrast, drug holidays showed no effect on improving outcomes in patients with both osteoporosis and malignant tumors who underwent surgical therapy. Thus, regardless of the primary disease, discontinuing antiresorptive agents during treatment for MRONJ may not be necessary and may be helpful in some cases. Future prospective trials should examine this question further.


  • Open Access

    Distribution and Origin of VIP‐, SP‐, and Phospholipase Cβ2‐Immunoreactive Nerves in the Tongue of the Bullfrog, Rana catesbeiana

    by Osamu Tadokoro, Hiroshi Ando, Ichiro Kawahara, Naokazu Asanuma, Masayo Okumura, Junichi Kitagawa, Eiji Kondo, Hiroshi Yagasaki

    Previous studies have found a few intralingual ganglionic cells that were immunoreactive to vasoactive intestinal polypeptide (VIP) in the frog. A recent study reported a large number of such cells, and the possibility of the release of substance P (SP) from these. The aim of the present study was to investigate the distribution, origin, and colocalization of VIP‐ and SP‐ immunoreactive nerves in the tongue of the bullfrog, R. catesbeiana. In addition, the study also examined the colocalization of SP and phospholipase Cβ2 (PLCβ2) in the tongue and jugular ganglion. VIP immunoreactivity was seen in unipolar cells that were sparse in nerve bundles in the submucosal and muscle layers. The density of VIP‐immunoreactive cells was approximately 4.8 cells/mm3. Their fibers terminated in the vicinity of the epithelial basal layer of the fungiform papillae. SP immunoreactivity was not seen in the VIP‐immunoreactive cells, but was observed in pseudounipolar cells in the jugular ganglion. The SP fibers terminated close to the free surface, showing spindle‐ and button‐like profiles. Transection of glossopharyngeal nerve resulted in the persistence of VIP‐immunoreactive cells and the disappearance of SP‐immunoreactive fibers in the tongue. SP immunoreactivity was co‐expressed with PLCβ2 in both the tongue and jugular ganglia. No PLCβ2 immunoreactivity was seen in cells comprising the epithelial taste disk. These findings indicate that the origin of VIP nerve fibers are unipolar cells in the tongue, and SP and PLCβ2 fibers originate from pseudounipolar cells that may be able to release SP primarily in the jugular ganglion. Anat Rec, 299:929–942, 2016.


  • Open Access

    The Endogenous Opioids Related with Antinociceptive Effects Induced by Electrical Stimulation into the Amygdala

    by Takami Nakamura, Mihoko Tomida, Toshiharu Yamamoto, Hiroshi Ando, Tetsuya Takamata, Eiji Kondo, Ikufumi Kurasawa, Naokazu Asanuma

    Pain relief is necessary and essential for dental treatments. Recently, the relationships of pain and emotion were studied, and electrical stimulation applied to the amygdala depressed the nociceptive response in the anterior cingulate cortex (ACC). Thus, the antinociceptive effects of the amygdala are elucidated, but its mechanism is not yet clarified. The present study was performed to investigate whether endogenous opioid system is related to the depression, and the quantitative changes of endogenous opioids induced by electrical stimulation to the amygdala. We investigated immunohistologically c-Fos expression to confirm the activated neurons, as well as the distribution and the amount of endogenous opioids (β-endorphin, enkephalin and dynorphin A) in the brain using male Wistar rats, when electrical stimulation was applied to the central nucleus of the amygdala (CeA) or noxious stimulation was delivered to the peripheral tissue. c-Fos expression in the ipsilateral ACC was increased by electrical stimulation to the CeA. However, only a small amount of endogenous opioids was observed in the ACC when noxious stimulation or electrical stimulation was applied. In contrast, the amount of dynorphin A in the periaqueductal gray (PAG) was increased by electrical stimulation to the CeA, and the amount of β-endorphin in the PAG was increased by noxious stimulation to the peripheral tissue. The results suggest that dynorphin A in the PAG induced by electrical stimulation to the CeA activate the descending antinociceptive system, and suggest that the nociceptive response in the ACC is depressed indirectly.